Log in
Enquire now
AbSci, LLC

AbSci, LLC

AbSci, LLC is an AI-powered synthetic biology company employing their Integrated Drug Creation™ Platform to accelerate discovery of novel biotherapeutic drug candidates.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
Sean McClain
Sean McClain
CIK Number
1,672,688
Company Operating Status
Closed
Crunchbase URL
crunchbase.com/organiz...on/absci
Date Incorporated
2017
Facebook URL
@abscibio
Founder
Sean McClain
Sean McClain
Full Address
101 E 6TH St Ste 300 Vancouver​, WA, 98660-3342 United States
Industry
Biopharma
Biopharma
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Biology
Biology
Technology
Technology
Biotechnology
Biotechnology
Life science
Life science
Machine learning
Machine learning
Investors
AGC
AGC
aMoon Fund
aMoon Fund
D1 Capital Partners
D1 Capital Partners
Irving Capital
Irving Capital
Casdin Capital
Casdin Capital
Redmile Group
Redmile Group
Perceptive Advisors
Perceptive Advisors
ArrowMark Partners
ArrowMark Partners
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
KBI Biopharma
KBI Biopharma
•••
Latest Funding Round Date
March 2021
Latest Funding Type
Series E
Series E
LinkedIn URL
@company/absci/about
Location
Vancouver, Washington
Vancouver, Washington
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
2
Total Funding Amount (USD)
222,500,000
Twitter URL
@abscibio
Official Website
abscibio.com

Find more companies like AbSci, LLC

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.